Key Highlights

● The Russell 2000 posted a stronger relative gain than large-cap indexes.

● Small caps are usually sensitive to borrowing costs.

● Deals and earnings drove big swings in individual names.

● Breadth among Nasdaq-listed small caps was healthier than the NYSE.

Small-company stocks outran their larger peers, as the Russell 2000 posted a stronger relative gain than the S&P 500, the Dow Jones Industrial Average or the Nasdaq Composite. Only the Nasdaq-100, propelled by chipmakers, did better among the major benchmarks.

The result was notable because small caps are usually sensitive to borrowing costs, since many smaller companies rely on floating-rate debt, so higher rates can squeeze their profits, and the day brought plenty of rate pressure from a hawkish Fed.

A Surprising Winner

Still, the two-year Treasury yield, which tracks Fed expectations most closely, edged slightly lower, and the Fed's message that economic activity is expanding at a strong pace is generally supportive for domestically focused smaller companies.

Much of the action came from individual stories, with Ultralife more than doubling after agreeing to be acquired by EnerSys in a cash deal, and Wendy's soaring after a reported take-private proposal from Trian.

A Mixed Day Beneath the Surface

Health care names delivered some of the biggest moves, with OrthoPediatrics rocketing after a raised forecast, while AI drug-discovery stocks rallied as a group with no company-specific news.

Some steep losses occurred too, with several biotechs sliding sharply, a reminder that small-cap rallies can be concentrated in a handful of names even when the broader index outperforms.